Results: 1-25 |
Results: 25

Authors: Kuttab, S Shang, J Castagnoli, N
Citation: S. Kuttab et al., Rat liver microsomal enzyme catalyzed oxidation of 4-phenyl-trans-1-(2-phenylcyclopropyl)-1,2,3,6-tetrahydropyridine, BIO MED CH, 9(7), 2001, pp. 1685-1689

Authors: Weidolf, L Castagnoli, N
Citation: L. Weidolf et N. Castagnoli, Study of the electrospray ionization mass spectrometry of the proton pump inhibiting drug Omeprazole, RAP C MASS, 15(4), 2001, pp. 283-290

Authors: Kalgutkar, AS Dalvie, DK Castagnoli, N Taylor, TJ
Citation: As. Kalgutkar et al., Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors, CHEM RES T, 14(9), 2001, pp. 1139-1162

Authors: Castagnoli, KP Steyn, SJ Petzer, JP Van der Schyf, CJ Castagnoli, N
Citation: Kp. Castagnoli et al., Neuroprotection in the MPTP parkinsonian C57BL/6 mouse model by a compoundisolated from tobacco, CHEM RES T, 14(5), 2001, pp. 523-527

Authors: Chen, JF Xu, K Petzer, JP Staal, R Xu, YH Beilstein, M Sonsalla, PK Castagnoli, K Castagnoli, N Schwarzschild, MA
Citation: Jf. Chen et al., Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in amodel of Parkinson's disease, J NEUROSC, 21(10), 2001, pp. NIL_1-NIL_6

Authors: Isin, EM de Jonge, M Castagnoli, N
Citation: Em. Isin et al., Studies on synthetic approaches to 1H- and 2H-indazolyl derivatives, J ORG CHEM, 66(12), 2001, pp. 4220-4226

Authors: Steyn, SJ Castagnoli, K Steyn, S Castagnoli, N
Citation: Sj. Steyn et al., Selective inhibition of MAO-B through chronic low-dose (R)-deprenyl treatment in C57BL/6 mice has no effect on basal neostriatal dopamine levels, EXP NEUROL, 168(2), 2001, pp. 434-436

Authors: Tanko, JM Friedline, R Suleman, NK Castagnoli, N
Citation: Jm. Tanko et al., tert-butoxyl as a model for radicals in biological systems: Caveat emptor, J AM CHEM S, 123(24), 2001, pp. 5808-5809

Authors: Ooms, F Delvosal, S Wouters, J Durant, F Dockendolf, G Van't Land, C Glass, T Castagnoli, N Van der Schyf, CJ
Citation: F. Ooms et al., Empirical and molecular modeling study of the pyridinium species RHPP+, anabundant and potentially neurotoxic metabolite of haloperidol, J CHEM S P2, (9), 2000, pp. 1781-1787

Authors: Igarashi, K Sugiyama, Y Kasuya, F Inoue, H Matoba, R Castagnoli, N
Citation: K. Igarashi et al., Analysis of citrulline in rat brain tissue after perfusion with haloperidol by liquid chromatography-mass spectrometry, J CHROMAT B, 746(1), 2000, pp. 33-40

Authors: Liu, X Castagnoli, K Van der Schyf, CJ Castagnoli, N
Citation: X. Liu et al., Studies on the in vivo biotransformation of the tobacco alkaloid beta-nicotyrine, CHEM RES T, 13(5), 2000, pp. 336-341

Authors: Khalil, AA Steyn, S Castagnoli, N
Citation: Aa. Khalil et al., Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves, CHEM RES T, 13(1), 2000, pp. 31-35

Authors: Ooms, F Norberg, B Isin, EM Castagnoli, N Van der Schyf, CJ Wouters, J
Citation: F. Ooms et al., 7-Nitroindazole, ACT CRYST C, 56, 2000, pp. E474-E475

Authors: Petzer, JP Bergh, JJ Mienie, LJ Castagnoli, N Van der Schyf, CJ
Citation: Jp. Petzer et al., Metabolic defects caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and by HPTP (the tetrahydropyridinyl analog of haloperidol), in rats, LIFE SCI, 66(20), 2000, pp. 1949-1954

Authors: Yu, J Castagnoli, N
Citation: J. Yu et N. Castagnoli, Synthesis and MAO-B substrate properties of 1-methyl-4-heteroaryl-1,2,3,6-tetrahydropyridines, BIO MED CH, 7(2), 1999, pp. 231-239

Authors: Yu, JA Castagnoli, N
Citation: Ja. Yu et N. Castagnoli, Synthesis and monoamine oxidase B substrate properties of 1-methyl-4-heteroaryl-1,2,3,6-tetrahydropyridines, BIO MED CH, 7(12), 1999, pp. 2835-2842

Authors: Liu, X Zang, LY Van der Schyf, CJ Igarashi, K Castagnoli, K Castagnoli, N
Citation: X. Liu et al., Studies on the pyrrolinone metabolites derived from the tobacco alkaloid 1-methyl-2-(3-pyridinyl)pyrrole (beta-nicotyrine), CHEM RES T, 12(6), 1999, pp. 508-512

Authors: Mienie, LJ Bergh, JJ Bloomquist, JR Castagnoli, N Steyn, SJ Van der Schyf, CJ
Citation: Lj. Mienie et al., p-Fluorophenylglycine in the urine of baboons treated with HPTP, the tetrahydropyridine analog of haloperidol, LIFE SCI, 65(5), 1999, pp. 535-542

Authors: Inoue, H Castagnoli, K Van der Schyf, C Mabic, S Igarashi, K Castagnoli, N
Citation: H. Inoue et al., Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinyl derivatives, J PHARM EXP, 291(2), 1999, pp. 856-864

Authors: Nimkar, SK Mabic, S Anderson, AH Palmer, SL Graham, TH de Jonge, M Hazelwood, L Hislop, SJ Castagnoli, N
Citation: Sk. Nimkar et al., Studies on the monoamine oxidase-B-catalyzed biotransformation of 4-azaaryl-1-methyl-1,2,3,6-tetrahydropyridine derivatives, J MED CHEM, 42(10), 1999, pp. 1828-1835

Authors: Halliday, GM Pond, SM Cartwright, H McRitchie, DA Castagnoli, N Van der Schyf, CJ
Citation: Gm. Halliday et al., Clinical and neuropathological abnormalities in baboons treated with HPTP,the tetrahydropyridine analog of haloperidol, EXP NEUROL, 158(1), 1999, pp. 155-163

Authors: Mabic, S Castagnoli, K Castagnoli, N
Citation: S. Mabic et al., Oxidative metabolic bioactivation of xenobiotics, HANDBOOK OF DRUG METABOLISM, 1999, pp. 49-79

Authors: Zhao, ZY Mabic, S Kuttab, S Franot, C Castagnoli, K Castagnoli, N
Citation: Zy. Zhao et al., Rat liver microsomal enzyme catalyzed oxidation of 1-cyclopropyl-4-phenyl-1,2,3,6-tetrahydropyridine, BIO MED CH, 6(12), 1998, pp. 2531-2539

Authors: McRitchie, DA Cartwright, H Pond, SM van der Schyf, CJ Castagnoli, N van der Nest, DG Halliday, GM
Citation: Da. Mcritchie et al., The midbrain dopaminergic cell groups in the baboon Papio ursinus, BRAIN RES B, 47(6), 1998, pp. 611-623

Authors: Usuki, E Van der Schyf, CJ Castagnoli, N
Citation: E. Usuki et al., Metabolism of haloperidol and its tetrahydropyridine dehydration product HPTP, DRUG METAB, 30(4), 1998, pp. 809-826
Risultati: 1-25 |